Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	290.87	264.55	270.5	157.64	137.98
Cash & Short-Term Investments	290.87	264.55	270.5	157.64	137.98
Cash Growth	9.95%	-2.20%	71.60%	14.25%	-12.69%
Accounts Receivable	223.8	184.33	135.04	131.31	122.42
Other Receivables	11.57	23.59	26.38	10.84	10.31
Receivables	235.37	207.92	161.42	142.15	132.72
Inventory	293.17	248.55	243.07	235.18	222.19
Prepaid Expenses	-	5.39	2.08	6.52	1.9
Total Current Assets	819.41	726.4	677.07	541.49	494.8
Property, Plant & Equipment	554.08	567.52	582.37	579.92	542.53
Long-Term Investments	16.48	22.67	36.91	42.15	73.54
Other Intangible Assets	36.88	7.32	7.65	3.84	4.95
Long-Term Deferred Tax Assets	20.4	15.33	8.95	13.33	12.7
Long-Term Deferred Charges	-	37.55	31.15	40.14	34.58
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.05
Total Assets	1,448	1,378	1,345	1,222	1,164
Accounts Payable	162.24	55.89	40.45	51.93	31.32
Accrued Expenses	-	46.92	33.79	40.46	61.2
Short-Term Debt	-	32.33	50.59	101.8	87.85
Current Portion of Long-Term Debt	147.42	15.66	14.95	32.34	15.08
Current Portion of Leases	-	0.55	0.92	0.94	0.64
Current Income Taxes Payable	4.29	0.74	0.37	1.17	6.06
Other Current Liabilities	-	25.89	25.65	35.95	28.17
Total Current Liabilities	313.96	177.99	166.73	264.59	230.31
Long-Term Debt	345.47	464.52	480.9	294.6	297.8
Long-Term Leases	2.82	2.76	1.48	1.92	2.48
Long-Term Deferred Tax Liabilities	28.43	23.42	8.91	5.58	9.54
Total Liabilities	690.68	668.68	658.01	566.7	540.13
Common Stock	432.47	432.47	432.47	419.37	405.86
Retained Earnings	408.57	354.78	319.07	288.37	239.97
Comprehensive Income & Other	-83.41	-78.09	-64.41	-52.52	-21.82
Shareholders' Equity	757.62	709.15	687.12	655.22	624
Total Liabilities & Equity	1,448	1,378	1,345	1,222	1,164
Total Debt	495.72	515.82	548.85	431.6	403.84
Net Cash (Debt)	-204.85	-251.28	-278.35	-273.97	-265.86
Net Cash Per Share	-0.21	-0.26	-0.29	-0.29	-0.29
Filing Date Shares Outstanding	961.94	961.94	961.94	952.24	941.77
Total Common Shares Outstanding	961.94	961.94	961.94	952.24	941.77
Working Capital	505.45	548.42	510.34	276.9	264.49
Book Value Per Share	0.79	0.74	0.71	0.69	0.66
Tangible Book Value	720.74	701.84	679.47	651.38	619.06
Tangible Book Value Per Share	0.75	0.73	0.71	0.68	0.66
Land	-	65.68	65.68	69.88	69.88
Buildings	-	267.09	265.86	125.23	124.51
Machinery	-	452.39	435.18	368.47	308.94
Construction In Progress	-	12.19	8.48	172.65	162.63

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.